Records containing: Mycosis Fungoides
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-08-30Phase II Study of Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides
-
CLINICAL_TRIALS study record update · 2016-06-24Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
-
CLINICAL_TRIALS study record update · 2016-02-17Open Label Pilot Study of Combination Therapy With Rosiglitazone and Bexarotene to Investigate a Possible Synergism in the Treatment of Cutaneous T-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2015-05-22The Effectiveness of UVA1 and UVB Irradiation in the Treatment of Inflammatory Dermatoses: An Open Pilot Study
-
CLINICAL_TRIALS study record update · 2015-03-25Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-08-01Le23 CPG: A Phase 1-2 Study of Intratumoral Injection of CPG 7909, A TLR 9 Agonist, Combined With Local Radiation in Recurrent Low-Grade Lymphomas
-
CLINICAL_TRIALS study record update · 2014-05-28In Vitro Evaluation of Immune Responses in CTCL
-
CLINICAL_TRIALS study record update · 2012-10-31A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients With Stage I or IIA Mycosis Fungoides (MF)
-
CLINICAL_TRIALS study record update · 2012-08-09An Open Label Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (Mechlorethamine - MCH) 0.04% Formulation in Patients With Stage I-IIA Mycosis Fungoides Who Have Completed 12 Months Treatment Without a Complete Response
-
CLINICAL_TRIALS study record update · 2012-07-26Open Label, Dose Escalation, Followed by Open Label,Single Arm Clinical Trial of HuMax-CD4 in Patients With Mycosis Fungoides Type CTCL (Stage IB-IVB) or Sezary Syndrome Who Are Refractory or Intolerant to Targretin® (Bexarotene) and One Other Standard Therapy
-
CLINICAL_TRIALS study record update · 2008-03-05A Multicenter Phase III Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy of Two Dose Levels of DAB389IL-2 (9 and 18 Mcg/kg/Day) in Cutaneous T-Cell Lymphoma (CTCL) Patients With Stage Ia-III Disease Who, Following Less Than or Equal to 3 Previous Therapies, Have Recurrent or Persistent Disease That Has Been Biopsy-Documented to Express CD25
-
CLINICAL_TRIALS study record update · 2008-03-05A Multicenter Open-Label Study to Evaluate the Safety and Efficacy of DAB389IL-2 in Cutaneous T-Cell Lymphoma (CTCL) Patients Following Protocol 93-04-10, Protocol 93-04-11, or Protocol 92-04-01 or Who Meet the Requirements for Protocol 93-04-11 Except Have Biopsy-Documented CTCL That Does Not Express CD25
-
CLINICAL_TRIALS study record update · 2007-07-04A Prospective, Open-Label Study on Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides
-
CLINICAL_TRIALS study record update · 2007-04-03Phase II Study of Alemtuzumab in Patients With Advanced Mycosis Fungoides/Sezary Syndrome